<DOC>
	<DOCNO>NCT00544206</DOCNO>
	<brief_summary>To compare glucose response tube feed subject type 2 diabetes standard enteral product diabetes-specific enteral product</brief_summary>
	<brief_title>Comparison Enteral Products Tube Fed Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>sign date informed consent diagnosis type 2 diabetes HbA1c 7.0 9.0 % 18 75 year age currently receive standard enteral product anticipate duration tube feed least one month 100 % patient 's nutrient energy need anticipate meet enteral nutrition support anticipate life expectancy equal 6 month free infection change medication within 2 week prior screen could profoundly affect blood glucose composition either product inappropriate patient due allergy intolerance ingredient find study product composition either product inappropriate patient due protein , fluid electrolyte restriction concomitant condition significant cardiovascular event less equal 2 week prior study entry major surgery less equal 2 week prior study entry preplanned surgery study period active malignancy , include melanoma exclude cutaneous malignancy severe dementia know allergy medical grade adhesive and/or skin disinfectant take octreotide chronic , contagious , infectious disease , active tuberculosis , Hepatitis B C , HIV participation concomitant trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>